Artificial intellingence and my open access Polymyalgia Rheumatica Paper

What a surprise!

AI wrote a review of my paper „Polymyalgia Rheumatica, an Age-Related Rheumatic Disease”, which has reached 8000 views and 800 downloads so far. The paper was published as an open access publication by OBM Geriatrics. https://lidsen.com/journals/geriatrics/geriatrics-06-03-202

The AI report appeared in Academia.edu, which  is a commercial platform for sharing academic research that is uploaded and distributed by researchers from around the world. My co-author was the Széchenyi prize winner Academic, Professor Gyula Poór.

The AI review https://www.academia.edu/ai_review/85007778  gives an overview of the paper, relevant references, and after emphasizing the strengths, major and minor comments are enrolled to improve future publishing.

Reviewer Commentary is a concise evaluation of the paper’s timely relevance, in our aging society and molecular biology era. "This review raises important interdisciplinary considerations, particularly in how PMR is understood across different medical specialties, from rheumatology to gerontology. It invites further exploration into the social and economic impacts of PMR, especially concerning healthcare resource allocation for aging populations. Additionally, the potential classification of PMR as an autoinflammatory disorder may open new avenues of research into its pathogenesis, with significant implications for patient management and therapeutic development."

Then Summary Assessment comes, which is fully  shown here:

“Overall, this work makes a significant intellectual contribution by synthesizing current knowledge on PMR and positioning it within the context of related rheumatic disorders. The review advances the conversation on PMR by integrating clinical, epidemiological, and pathophysiological perspectives, thereby encouraging a more nuanced understanding of this complex disease. Future directions might include a closer examination of the interplay between genetics, environment, and immune response, potentially advancing personalized medicine approaches in rheumatology.

In conclusion, the work effectively highlights the ongoing challenges and emerging opportunities in the understanding and management of Polymyalgia Rheumatica, offering valuable insights for clinicians, researchers, and policymakers alike.”